240 related articles for article (PubMed ID: 14586388)
1. The bioavailability of intranasal and smoked methamphetamine.
Harris DS; Boxenbaum H; Everhart ET; Sequeira G; Mendelson JE; Jones RT
Clin Pharmacol Ther; 2003 Nov; 74(5):475-86. PubMed ID: 14586388
[TBL] [Abstract][Full Text] [Related]
2. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.
Cook CE; Jeffcoat AR; Hill JM; Pugh DE; Patetta PK; Sadler BM; White WR; Perez-Reyes M
Drug Metab Dispos; 1993; 21(4):717-23. PubMed ID: 8104133
[TBL] [Abstract][Full Text] [Related]
4. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
Rivière GJ; Byrnes KA; Gentry WB; Owens SM
J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
[TBL] [Abstract][Full Text] [Related]
8. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioequivalence of the main metabolites of selegiline: desmethylselegiline, methamphetamine and amphetamine after oral administration of selegiline.
Mascher HJ; Kikuta C; Millendorfer A; Schiel H; Ludwig G
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):9-13. PubMed ID: 9021435
[TBL] [Abstract][Full Text] [Related]
10. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects.
Foltin RW; Haney M
Pharmacol Biochem Behav; 2004 May; 78(1):93-101. PubMed ID: 15159138
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
Foster D; Upton R; Christrup L; Popper L
Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
Kirkpatrick MG; Gunderson EW; Johanson CE; Levin FR; Foltin RW; Hart CL
Addiction; 2012 Apr; 107(4):783-91. PubMed ID: 22050030
[TBL] [Abstract][Full Text] [Related]
13. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking.
Jeffcoat AR; Perez-Reyes M; Hill JM; Sadler BM; Cook CE
Drug Metab Dispos; 1989; 17(2):153-9. PubMed ID: 2565204
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and effects of aminorex in horses.
Soma LR; Rudy JA; Uboh CE; Xu F; Snapp HM
Am J Vet Res; 2008 May; 69(5):675-81. PubMed ID: 18447801
[TBL] [Abstract][Full Text] [Related]
15. A review of the clinical pharmacology of methamphetamine.
Cruickshank CC; Dyer KR
Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers.
Dowling J; Isbister GK; Kirkpatrick CM; Naidoo D; Graudins A
Ther Drug Monit; 2008 Aug; 30(4):490-6. PubMed ID: 18641540
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of tramadol in rat plasma and cerebrospinal fluid after intranasal administration.
Zhao Y; Tao T; Wu J; Pi J; He N; Chai X; Chen Q
J Pharm Pharmacol; 2008 Sep; 60(9):1149-54. PubMed ID: 18718117
[TBL] [Abstract][Full Text] [Related]
18. The relationship between crystalline methamphetamine use and methamphetamine dependence.
McKetin R; Kelly E; McLaren J
Drug Alcohol Depend; 2006 Dec; 85(3):198-204. PubMed ID: 16723192
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
[TBL] [Abstract][Full Text] [Related]
20. Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose.
Li L; Lopez JC; Galloway GP; Baggott MJ; Everhart T; Mendelson J
Ther Drug Monit; 2010 Aug; 32(4):504-7. PubMed ID: 20592647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
